Zobrazeno 1 - 10
of 114
pro vyhledávání: '"dnajb9"'
Autor:
Minchenko Dmytro O., Khita Olena O., Viletska Yuliia M., Sliusar Myroslava Y., Rudnytska Olha V., Kozynkevych Halyna E., Bezrodnyi Borys H., Khikhlo Yevgen P., Minchenko Oleksandr H.
Publikováno v:
Endocrine Regulations, Vol 58, Iss 1, Pp 1-10 (2024)
Objective. Glucocorticoids are important stress-responsive regulators of insulin-dependent metabolic processes realized through specific changes in genome function. The aim of this study was to investigate the impact of cortisol on insulin receptor a
Externí odkaz:
https://doaj.org/article/b609e490dc3c40e88c18f131f83ee809
Autor:
Minchenko Oleksandr, Kulish Yuliia V., Viletska Yuliia M., Khita Olena O., Rudnytska Olha V., Kozynkevych Halyna E., Minchenko Dmytro O.
Publikováno v:
Endocrine Regulations, Vol 58, Iss 1 (2024)
Objective. Nanographene oxide (nGO) nanoparticles (NPs) have unique properties and are widely used in various fields, including biomedicine. These NPs, however, also exhibit toxic effects and therefore, the understanding of the molecular mechanism
Externí odkaz:
https://doaj.org/article/6299f828db9e43e8b2edc77ee876dee1
Autor:
Furkan Bestepe, Colette Fritsche, Kartik Lakhotiya, Carolyn E. Niosi, George F. Ghanem, Gregory L. Martin, Ruma Pal-Ghosh, Dakota Becker-Greene, James Weston, Ivana Hollan, Ivar Risnes, Stein Erik Rynning, Liv Heidi Solheim, Mark W. Feinberg, Robert M. Blanton, Basak Icli
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 32, Iss , Pp 995-1009 (2023)
Angiogenesis is critical for tissue repair following myocardial infarction (MI), which is exacerbated under insulin resistance or diabetes. MicroRNAs are regulators of angiogenesis. We examined the metabolic regulation of miR-409-3p in post-infarct a
Externí odkaz:
https://doaj.org/article/900c2a0bbc3d4984a95a1425cd183424
Autor:
Minchenko Dmytro O., Rudnytska Olha V., Khita Olena O., Kulish Yuliia V., Viletska Yuliia M., Halkin Oleh V., Danilovskyi Serhiy V., Ratushna Oksana O., Minchenko Oleksandr H.
Publikováno v:
Endocrine Regulations, Vol 57, Iss 1, Pp 162-172 (2023)
Objective. Single-walled carbon nanotubes (SWCNTs) are considered to be one of the nanomaterials attractive for biomedical applications, particularly in the health sciences as imaging probes and drug carriers, especially in the field of cancer therap
Externí odkaz:
https://doaj.org/article/18a811d499954a08a86a5931c08b6421
Autor:
Fateme Shamekhi Amiri
Publikováno v:
Počki, Vol 11, Iss 3, Pp 136-153 (2022)
Background. Fibrillary glomerulonephritis is a rare glomerular disease that presents with hypertension, hematuria, nephrotic syndrome and renal insufficiency. The purpose of this research was to assess effect of DNAjB9 staining marker in kidney biops
Externí odkaz:
https://doaj.org/article/68f2bc657f2446b7a469cd7a31e117d8
Autor:
Nicole K. Andeen, Vanderlene L. Kung, Josh Robertson, Susan B. Gurley, Rupali S. Avasare, Sneha Sitaraman
Publikováno v:
Glomerular Diseases, Pp 1-12 (2022)
Background: Fibrillary glomerulonephritis (FGN) is found in approximately 1% of native kidney biopsies and was traditionally defined by glomerular deposition of fibrils larger than amyloid (12–24 nm diameter) composed of polyclonal IgG. Recent iden
Externí odkaz:
https://doaj.org/article/94ef4ab5e4af4d258470275268734ed2
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Fibrillary glomerulonephritis (FGN) is a rare glomerular disease featured by the randomly arranged 12- to 24-nm fibrils under electron microscopy (EM). Up to 10% of FGN patients have monoclonal gammopathy. However, distinguishing between FGN as monoc
Externí odkaz:
https://doaj.org/article/8c1aecb0918c494384c458cc91342980
Autor:
Alessandro Gambella, Chiara Pitino, Antonella Barreca, Alberto Nocifora, Manuela Maria Giarin, Luca Bertero, Luigi Biancone, Dario Roccatello, Mauro Papotti, Paola Cassoni
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2102 (2022)
Fibrillary glomerulonephritis (FGN) is a rare glomerular disease characterized by a challenging diagnostic workup requiring ultrastructural identification of 20 nm-thick randomly oriented fibrillar deposits. However, the recent introduction of DNAJB9
Externí odkaz:
https://doaj.org/article/7ee1a36848e94bdeaa839e77b0c9ea7e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Samih H. Nasr, Julie A. Vrana, Surendra Dasari, Frank Bridoux, Mary E. Fidler, Sihem Kaaki, Nathalie Quellard, Alexia Rinsant, Jean Michel Goujon, Sanjeev Sethi, Fernando C. Fervenza, Lynn D. Cornell, Samar M. Said, Ellen D. McPhail, Loren P. Herrera Hernandez, Joseph P. Grande, Marie C. Hogan, John C. Lieske, Nelson Leung, Paul J. Kurtin, Mariam P. Alexander
Publikováno v:
Kidney International Reports, Vol 3, Iss 1, Pp 56-64 (2018)
Fibrillary glomerulonephritis (FGN) is a rare disease with unknown pathogenesis and a poor prognosis. Until now, the diagnosis of this disease has required demonstration of glomerular deposition of randomly oriented fibrils by electron microscopy tha
Externí odkaz:
https://doaj.org/article/5a6bfb80b6b44dfca60e41125f0467d5